504 related articles for article (PubMed ID: 215969)
21. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
[TBL] [Abstract][Full Text] [Related]
23. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
Fark AR
J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
25. [Heterophil antibody negative infectious mononucleosis due to Epstein-Barr virus. A clinical, hematological and serological study of 14 cases (author's transl)].
Gout JP; Seigneurin D; Seigneurin JM; Bost M; Micoud M
Sem Hop; 1980 Mar 8-15; 56(9-10):434-8. PubMed ID: 6244662
[TBL] [Abstract][Full Text] [Related]
26. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
[TBL] [Abstract][Full Text] [Related]
27. Encephalitis in infectious mononucleosis.
Todman DH
Clin Exp Neurol; 1983; 19():81-6. PubMed ID: 6096052
[TBL] [Abstract][Full Text] [Related]
28. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
29. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV
Lab Delo; 1989; (5):73-4. PubMed ID: 2473271
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus in the mononucleosis syndrome in children.
Najberg G; Jankowski M; Krotochwil-Skrzypkowa M; Gut W
Acta Microbiol Pol; 1985; 34(2):137-44. PubMed ID: 2412401
[TBL] [Abstract][Full Text] [Related]
31. Limitations of immunofluorescence tests in the diagnosis of infectious mononucleosis.
Joncas JH; Gilker JC; Chagnon A
Can Med Assoc J; 1974 Apr; 110(7):793-4 passim. PubMed ID: 4363398
[TBL] [Abstract][Full Text] [Related]
32. Primary Epstein-Barr-virus infections in acute neurologic diseases.
Grose C; Henle W; Henle G; Feorino PM
N Engl J Med; 1975 Feb; 292(8):392-5. PubMed ID: 163004
[TBL] [Abstract][Full Text] [Related]
33. Encephalitis in infectious mononucleosis: diagnostic considerations.
Lange BJ; Berman PH; Bender J; Henle W; Hewetson JF
Pediatrics; 1976 Dec; 58(6):877-80. PubMed ID: 186753
[TBL] [Abstract][Full Text] [Related]
34. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
35. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
36. A systematic study of Epstein-Barr virus serologic assays following acute infection.
Rea TD; Ashley RL; Russo JE; Buchwald DS
Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
[TBL] [Abstract][Full Text] [Related]
37. [IgA antibodies against Epstein-Barr virus capsid antigen].
Chalupa P; Slesinger P; Krchnáková A; Prásek J
Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
[TBL] [Abstract][Full Text] [Related]
38. [Epstein-Barr virus infection in children: study of infectious mononucleosis without heterophil antibodies].
Baccard C; François P; Bost M; Bachelot C; Decret M; Beaudoing A; Seigneurin JM
Ann Pediatr (Paris); 1983 Jun; 30(6):416-21. PubMed ID: 6309061
[No Abstract] [Full Text] [Related]
39. [Persistent Epstein-Barr virus infection].
Schneider H; Jobke A; Pernice W
Monatsschr Kinderheilkd; 1985 Dec; 133(12):897-900. PubMed ID: 3878942
[TBL] [Abstract][Full Text] [Related]
40. Development of immunity to Epstein-Barr virus in Malaysian children.
Yadav MS; Malliga N; Ablashi DV
Microbiologica; 1987 Jan; 10(1):29-35. PubMed ID: 3033449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
